查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
到 2028 年亚太地区可流动止血剂市场预测 - 区域分析 - 按材料、产品、应用和最终用户
市场调查报告书
商品编码
1494344

到 2028 年亚太地区可流动止血剂市场预测 - 区域分析 - 按材料、产品、应用和最终用户

Asia Pacific Flowable Hemostats Market Forecast to 2028 - Regional Analysis - by Material, Product, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 138 Pages | 订单完成后即时交付

价格

亚太地区可流动止血剂市场预计将从2022年的1.7664亿美元成长到2028年的2.7519亿美元。

医院和手术中心数量的增加推动了亚太地区可流动止血剂市场

伤害仍然是公众健康的重大问题。全球创伤和事故病例的增加是亚太地区可流动止血剂市场的主要驱动力。根据世界卫生组织 (WHO) 统计，每年约有 130 万人因道路交通事故而缩短生命。 20 至 5000 万人遭受非致命伤害，其中许多人因受伤而残疾。在全球范围内，超过三分之一的院前死亡和超过 40% 的 24 小时内死亡是由出血或失血过多造成的。由于与运动、职业伤害和年龄相关的功能障碍相关的肌肉骨骼疾病的增加，手术数量不断增加。然而，由于运动相关的伤害，很大一部分健康收益被损失了。美国国家医学图书馆报告指出，与其他国家相比，中国患有创伤性脑损伤 (TBI) 的患者基数较大，这使得这种情况成为主要的公共卫生问题。因此，不断增加的伤害和外科手术导致了流动止血剂的大量采用，从而推动了预测期内市场的成长。

亚太地区可流动止血剂市场概况

亚太地区流动止血剂市场分为中国、日本、印度、韩国、澳洲和亚太地区其他地区。亚太地区预计将成为所有其他地区中成长最快的地区。由于对医疗保健行业基础设施发展的投资、外科手术数量的增加、对提供卓越手术结果的日益重视以及有利的监管批准，亚太地区的市场增长预计将以更快的速度增长。中国在亚太地区流动止血剂市场中占有相当大的份额。由于人们越来越重视提供优质的外科护理，以及对现代医疗器材的需求不断增长，预计该市场将会成长。出血性疾病盛行率的上升为可流动止血剂的设计、开发和试验铺平了道路。根据中国血友病治疗中心协作网络（HTCCNC）的研究，2007年至2019年，HTCCNC共识别出17,779名A型血友病患者。的血友病家族史。在实验室测量的疾病严重程度的患者中(N = 13,116)，6,519 名患者患有重度HA (49.7%)，4,788 名患者患有中度HA (36.5%)，1,809 名患者患有轻度HA (13.8%)。因此，在预测期内，血友病发生率的上升将增加对可流动止血剂的需求。

亚太地区可流动止血剂市场收入及 2028 年预测（百万美元）

亚太地区流动止血剂市场区隔

亚太地区可流动止血剂市场分为材料、产品、应用、最终用户和国家。

根据材料，亚太地区流动止血剂市场分为牛明胶和猪明胶。 2022 年，牛明胶细分市场在亚太地区可流动止血剂市场中占据更大份额。

从产品角度来看，亚太地区可流动止血器市场分为组合止血器、被动式止血器和主动式止血器。 2022 年，组合止血剂细分市场在亚太地区可流动止血剂市场中占据最大份额。

根据应用，亚太地区可流动止血剂市场分为一般外科、心臟外科、血管外科、骨科外科、神经和脊椎外科等。 2022 年，一般外科细分市场在亚太地区可流动止血剂市场中占最大份额。

根据最终用户，亚太地区可流动止血剂市场分为医院和诊所、门诊手术中心等。 2022 年，医院和诊所领域在亚太地区流动止血剂市场中占据最大份额。

依国家/地区划分，亚太地区流动止血剂市场分为中国、日本、印度、韩国、澳洲和亚太地区其他地区。 2022年，中国将主导亚太地区流动止血剂市场。

Baxter International Inc、Ethicon (Johnson & Johnson)、Pfizer Inc、Teleflex Incorporated、3-D Matrix Medical Technology 和 Aegis Lifesciences 是亚太流动止血剂市场上的一些领先公司。

目录

第 1 章：简介

第 2 章：要点

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：亚太地区可流动止血剂市场 - 市场格局

  • 概述
    • 亚太地区 PEST 分析
  • 亚太地区专家意见

第 5 章：亚太地区可流动止血剂市场 - 主要市场动态

  • 市场驱动因素
    • 受伤和手术数量不断增加
    • 老年人口增加
  • 市场限制
    • 熟练专业人员短缺和报销政策不佳
  • 市场机会
    • 医院和手术中心数量不断增加
  • 未来的趋势
    • 导致产品创新的研发 (R&D) 活动
  • 影响分析

第 6 章：可流动止血剂市场 - 亚太地区分析

  • 亚太地区可流动止血剂市场收入预测与分析
    • 亚太地区可流动止血剂市场收入预测与分析

第 7 章：亚太地区可流动止血器市场分析 - 依材料

  • 2021 年及 2028 年亚太地区可流动止血剂市占率（依材料）（%）
  • 牛明胶
  • 猪明胶

第 8 章：亚太地区可流动止血剂市场 - 按产品

  • 概述
  • 2021 年及 2028 年亚太地区可流动止血剂市占率（按产品）（%）
  • 组合止血钳
    • 概述
    • 组合止血器：亚太地区可流动止血器市场 - 收入与 2028 年预测
  • 被动止血器
    • 概述
    • 被动止血器：亚太地区可流动止血器市场 - 收入和 2028 年预测
  • 主动止血器
    • 概述
    • 主动止血器：亚太地区可流动止血器市场 - 收入与 2028 年预测

第 9 章：亚太地区可流动止血剂市场 - 按应用

  • 概述
  • 2021 年及 2028 年亚太地区可流动止血剂市占率（按应用划分）（%）
  • 一般外科
    • 概述
    • 一般外科：亚太地区可流动止血剂市场 - 收入和 2028 年预测
  • 心臟外科
    • 概述
    • 心臟手术：亚太地区可流动止血剂市场 - 收入和 2028 年预测
  • 血管外科
    • 概述
    • 血管外科：亚太地区可流动止血剂市场 - 收入和 2028 年预测
  • 骨科手术
    • 概述
    • 骨科手术：亚太地区可流动止血剂市场 - 收入和 2028 年预测
  • 神经和脊椎外科
    • 概述
    • 神经和脊椎外科：亚太地区可流动止血剂市场 - 收入和 2028 年预测
  • 其他的
    • 概述
    • 其他：亚太地区可流动止血剂市场 - 收入和 2028 年预测

第 10 章：亚太地区可流动止血器市场分析 - 按最终用户

  • 概述
  • 2021 年及 2028 年亚太地区可流动止血器市场占有率（依最终使用者）（%）
  • 医院和诊所
  • 门诊手术中心
  • 其他的

第 11 章：亚太地区可流动止血器市场收入和 2028 年预测 - 国家分析

  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 亚太地区其他地区

第 12 章：可流动止血剂市场-产业格局

  • 概述
  • 可流动止血剂市场的成长策略（%）
  • 有机发展
    • 概述
  • 无机发展
    • 概述

第 13 章：公司简介

  • Baxter International Inc
  • Ethicon (Johnson & Johnson)
  • Pfizer Inc.
  • Teleflex Incorporated
  • 3-D Matrix Medical Technology
  • Aegis Lifesciences

第 14 章：附录

Product Code: BMIRE00029829

The Asia Pacific flowable hemostats market is expected to grow from US$ 176.64 million in 2022 to US$ 275.19 million by 2028. It is estimated record a CAGR of 7.7% from 2022 to 2028.

Increasing Number of Hospitals and Surgical Centers Fuels Asia Pacific Flowable Hemostats Market

Injuries are still a significant concern to public health. An increase in global trauma and accident cases is a major driver of the Asia Pacific flowable hemostats market. According to World Health Organization (WHO), annually approximately 1.3 million people cut short their lives because of a road traffic crash. Between 20 to 50 million people suffer non-fatal injuries, with many incurring a disability because of their injury. Globally, hemorrhage or excessive bleeding is responsible for over one-third of pre-hospital deaths and over 40% of deaths within the first 24 hours. The number of surgeries is rising owing to the increasing musculoskeletal disorders related with sports, occupational injuries, and age-related dysfunction. However, a substantial proportion of health gains are lost owing to sports-related injuries. The National Library of Medicine report states China as a large base of patients agonizing traumatic brain injury (TBI) compared to other countries, making this condition a major public health concern. Thus, increasing number of injuries and surgical procedures are responsible for the high adoption of flowable hemostats, thereby driving the market's growth during the forecast period.

Asia Pacific Flowable Hemostats Market Overview

The Asia Pacific flowable hemostats market is segmented into China, Japan, India, South Korea, Australia, and the rest of Asia Pacific. The Asia Pacific region is expected to be the fastest-growing region among all other regions. The growth of market in the Asia Pacific region is expected to grow at a faster pace owing to investments made in the infrastructure development of the healthcare sector, rising number of surgical procedures, growing emphasis on providing superior surgical outcomes, and favorable regulatory approvals. China holds a considerable share in the Asia Pacific flowable hemostats market. The market is expected to grow owing to the growing emphasis on providing superior surgical care, and the growing demand for modern healthcare instruments. The rise in the prevalence of bleeding disorders has paved the way for the design, development, and piloting of flowable hemostats. According to a Hemophilia Treatment Center Collaboration Network of China (HTCCNC) study, HTCCNC identified 17,779 patients with Hemophilia A from 2007 to 2019. Patients were predominantly male (99.99%), and 28.3% had a known family history of hemophilia. Among patients with lab-measured disease severity (N = 13,116), 6,519 had severe HA (49.7%), 4,788 had moderate HA (36.5%), and 1,809 had mild HA (13.8%). Thus, rising incidences of hemophilia will increase the demand for flowable hemostats during the forecast period.

Asia Pacific Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Flowable Hemostats Market Segmentation

The Asia Pacific flowable hemostats market is segmented into material , product, application, end user, and country .

Based on material, the Asia Pacific flowable hemostats market is bifurcated into bovine gelatin and porcine gelatin. The bovine gelatin segment held a larger share of the Asia Pacific flowable hemostats market in 2022.

In terms of product , the Asia Pacific flowable hemostats market is segmented into combination hemostats , passive hemostats, and active hemostats . The combination hemostats segment held the largest share of the Asia Pacific flowable hemostats market in 2022.

Based on application , the Asia Pacific flowable hemostats market is categorized into general surgery , cardiac surgery, vascular surgery, orthopedic surgery, neuro and spine surgery, and others . The general surgery segment held the largest share of the Asia Pacific flowable hemostats market in 2022.

Based on end user , the Asia Pacific flowable hemostats market is segmented into hospitals and clinics , ambulatory surgery centers, and others . The hospitals and clinics segment held the largest share of the Asia Pacific flowable hemostats market in 2022.

By country, the Asia Pacific flowable hemostats market is categorized int o China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific flowable hemostats market in 2022.

Baxter International Inc, Ethicon (Johnson & Johnson), Pfizer Inc, Teleflex Incorporated, 3-D Matrix Medical Technology, and Aegis Lifesciences are some of the leading companies operating in the Asia Pacific flowable hemostats market.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Asia Pacific Flowable Hemostats Market - By Material
    • 1.3.2 Asia Pacific Flowable Hemostats Market - By Product
    • 1.3.3 Asia Pacific Flowable Hemostats Market - By Application
    • 1.3.4 Asia Pacific Flowable Hemostats Market - By End User
    • 1.3.5 Asia Pacific Flowable Hemostats Market - By Country

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Flowable Hemostats Market - Market Landscape

  • 4.1 Overview
    • 4.1.1 Asia Pacific PEST Analysis
  • 4.2 Asia Pacific Experts Opinion

5. Asia Pacific Flowable Hemostats Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Number of Injuries and Surgical Procedures
    • 5.1.2 Rising Geriatric Population
  • 5.2 Market Restraints
    • 5.2.1 Shortage of Skilled Professionals and Poor Reimbursement Policies
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Number of Hospitals and Surgical Centers
  • 5.4 Future Trends
    • 5.4.1 Research and Development (R&D) Activities Leading to Product Innovations
  • 5.5 Impact Analysis

6. Flowable Hemostats Market - Asia Pacific Analysis

  • 6.1 Asia Pacific Flowable Hemostats Market Revenue Forecast & Analysis
    • 6.1.1 Asia Pacific Flowable Hemostats Market Revenue Forecast & Analysis

7. Asia Pacific Flowable Hemostats Market Analysis - By Material

  • 7.1 Asia Pacific Flowable Hemostats Market Share, by Material, 2021 and 2028 (%)
  • 7.2 Bovine Gelatin
    • 7.2.1 Overview
    • 7.2.2 Bovine Gelatin: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 7.3 Porcine Gelatin
    • 7.3.1 Overview
    • 7.3.2 Porcine Gelatin: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

8. Asia Pacific Flowable Hemostats Market- By Product

  • 8.1 Overview
  • 8.2 Asia Pacific Flowable Hemostats Market Share, by Product, 2021 and 2028 (%)
  • 8.3 Combination Hemostat
    • 8.3.1 Overview
    • 8.3.2 Combination Hemostat: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Passive Hemostat
    • 8.4.1 Overview
    • 8.4.2 Passive Hemostat: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Active Hemostat
    • 8.5.1 Overview
    • 8.5.2 Active Hemostat: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Flowable Hemostats Market- By Application

  • 9.1 Overview
  • 9.2 Asia Pacific Flowable Hemostats Market Share, by Application, 2021 and 2028 (%)
  • 9.3 General Surgery
    • 9.3.1 Overview
    • 9.3.2 General Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Cardiac Surgery
    • 9.4.1 Overview
    • 9.4.2 Cardiac Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Vascular Surgery
    • 9.5.1 Overview
    • 9.5.2 Vascular Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Orthopedic Surgery
    • 9.6.1 Overview
    • 9.6.2 Orthopedic Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.7 Neuro and Spine Surgery
    • 9.7.1 Overview
    • 9.7.2 Neuro and Spine Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.8 Others
    • 9.8.1 Overview
    • 9.8.2 Others: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Flowable Hemostats Market Analysis - By End User

  • 10.1 Overview
  • 10.2 Asia Pacific Flowable Hemostats Market Share, by End User, 2021 and 2028, (%)
  • 10.3 Hospitals and Clinics
    • 10.3.1 Overview
    • 10.3.2 Hospitals and Clinics: Asia Pacific Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.4 Ambulatory Surgery Centers
    • 10.4.1 Overview
    • 10.4.2 Ambulatory Surgery Centers: Asia Pacific Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 Others: Asia Pacific Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)

11. Asia Pacific Flowable Hemostats Market Revenue and Forecasts to 2028 - Country Analysis

  • 11.1 Asia Pacific: Flowable Hemostats Market
    • 11.1.1 Overview
    • 11.1.2 Asia Pacific: Flowable Hemostats Market, by Country, 2021 & 2028 (%)
      • 11.1.2.1 China: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.1.1 China: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
        • 11.1.2.1.2 China: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.1.3 China: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.1.4 China: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.1.5 China: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
      • 11.1.2.2 Japan: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.2.1 Japan: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
        • 11.1.2.2.2 Japan: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.2.3 Japan: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.2.4 Japan: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.2.5 Japan: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
      • 11.1.2.3 India: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.3.1 India: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
        • 11.1.2.3.2 India: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.3.3 India: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.3.4 India: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.3.5 India: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
      • 11.1.2.4 South Korea: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.4.1 South Korea: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.4.2 South Korea: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.4.3 South Korea: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.4.4 South Korea: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.4.5 South Korea: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
      • 11.1.2.5 Australia: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.5.1 Australia: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.5.2 Australia: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.5.3 Australia: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.5.4 Australia: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.5.5 Australia: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
      • 11.1.2.6 Rest of Asia Pacific: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.6.1 Rest of Asia Pacific: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.6.2 Rest of Asia Pacific: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.6.3 Rest of Asia Pacific: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.6.4 Rest of Asia Pacific: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.6.5 Rest of Asia Pacific: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)

12. Flowable Hemostats Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Flowable Hemostats Market (%)
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Baxter International Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Ethicon (Johnson & Johnson)
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Pfizer Inc.
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Teleflex Incorporated
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 3-D Matrix Medical Technology
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Aegis Lifesciences
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments

14. Appendix

  • 14.1 About the Insight Partners
  • 14.2 Asia Pacific Glossary of Terms

List Of Tables

  • Table 1. China: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
  • Table 2. China: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 3. China: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
  • Table 4. China: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
  • Table 5. Japan: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
  • Table 6. Japan: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 7. Japan: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
  • Table 8. Japan: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
  • Table 9. India: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
  • Table 10. India: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 11. India: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
  • Table 12. India: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
  • Table 13. South Korea: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
  • Table 14. South Korea: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 15. South Korea: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
  • Table 16. South Korea: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
  • Table 17. Australia: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
  • Table 18. Australia: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 19. Australia: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
  • Table 20. Australia: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
  • Table 21. Rest of Asia Pacific: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
  • Table 22. Rest of Asia Pacific: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 23. Rest of Asia Pacific: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
  • Table 24. Rest of Asia Pacific: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
  • Table 25. Organic Developments in the Flowable Hemostats Market
  • Table 26. Inorganic Developments in the Flowable Hemostats Market
  • Table 27. Asia Pacific Glossary of Terms

List Of Figures

  • Figure 1. Asia Pacific Flowable Hemostats Market Segmentation
  • Figure 2. Asia Pacific Flowable Hemostats Market, By Country
  • Figure 3. Asia Pacific Flowable Hemostats Market Overview
  • Figure 4. Bovine Gelatin Holds Maximum Share in Asia Pacific Flowable Hemostats Market
  • Figure 5. Asia Pacific Flowable Hemostats Market, by Country (US$ Million)
  • Figure 6. Asia Pacific Flowable Hemostats Market, Market Attractiveness
  • Figure 7. Asia Pacific: PEST Analysis
  • Figure 8. Asia Pacific Experts Opinion
  • Figure 9. Impact Analysis
  • Figure 10. Asia Pacific Flowable Hemostats Market - Revenue Forecast and Analysis - 2020- 2028
  • Figure 11. Asia Pacific Flowable Hemostats market Share, by Material, 2021 and 2028 (%)
  • Figure 12. Bovine Gelatin: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Porcine Gelatin: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. Asia Pacific Flowable Hemostats Market Share, by Product, 2021 and 2028 (%)
  • Figure 15. Combination Hemostat: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Passive Hemostat: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Active Hemostat: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Asia Pacific Flowable Hemostats Market Share, by Application, 2021 and 2028 (%)
  • Figure 19. General Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Cardiac Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Vascular Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Orthopedic Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Neuro and Spine Surgery: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Others: Asia Pacific Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Asia Pacific Flowable Hemostats Gown Market Share, by End User, 2021 and 2028 (%)
  • Figure 26. Hospitals and Clinics: Asia Pacific Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Ambulatory Surgery Centers: Asia Pacific Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Others: Asia Pacific Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Asia Pacific Flowable Hemostats Market Revenue Overview, by Country, 2021 (US$ MN)
  • Figure 30. Asia Pacific: Flowable Hemostats Market, by Country, 2021 & 2028 (%)
  • Figure 31. China: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
  • Figure 32. Japan: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
  • Figure 33. India: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
  • Figure 34. South Korea: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
  • Figure 35. Australia: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
  • Figure 36. Rest of Asia Pacific: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
  • Figure 37. Growth Strategies in the Flowable Hemostats Market (%)